載入...
Nivolumab Beats Docetaxel as Second-Line Therapy for Patients with NSCLC
Na minha lista:
| 發表在: | Am Health Drug Benefits |
|---|---|
| 主要作者: | |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Engage Healthcare Communications, LLC
2015
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570080/ https://ncbi.nlm.nih.gov/pubmed/26380595 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|